Shandong Buchang Pharmaceuticals Statistics

Total Valuation

Shandong Buchang Pharmaceuticals has a market cap or net worth of CNY 15.77 billion. The enterprise value is 17.87 billion.

Market Cap	15.77B
Enterprise Value	17.87B

Important Dates

The next estimated earnings date is Monday, October 28, 2024.

Earnings Date	Oct 28, 2024
Ex-Dividend Date	Aug 20, 2024

Share Statistics

Shandong Buchang Pharmaceuticals has 1.08 billion shares outstanding. The number of shares has decreased by -0.42% in one year.

Shares Outstanding	1.08B
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	-0.88%
Owned by Insiders (%)	57.64%
Owned by Institutions (%)	5.73%
Float	429.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.37
PB Ratio	1.40
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.80, with an EV/FCF ratio of -46.89.

EV / Earnings	-91.27
EV / Sales	1.52
EV / EBITDA	18.80
EV / EBIT	30.20
EV / FCF	-46.89

Financial Position

The company has a current ratio of 1.28, with a Debt / Equity ratio of 36.30.

Current Ratio	1.28
Quick Ratio	0.48
Debt / Equity	36.30
Debt / EBITDA	4.20
Debt / FCF	-10.48
Interest Coverage	4.93

Financial Efficiency

Return on equity (ROE) is -3.06% and return on invested capital (ROIC) is 2.43%.

Return on Equity (ROE)	-3.06%
Return on Assets (ROA)	1.71%
Return on Capital (ROIC)	2.43%
Revenue Per Employee	1.41M
Profits Per Employee	-23,553
Employee Count	8,311
Asset Turnover	0.54
Inventory Turnover	1.03

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.22% in the last 52 weeks. The beta is 0.46, so Shandong Buchang Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.46
52-Week Price Change	-17.22%
50-Day Moving Average	15.09
200-Day Moving Average	16.25
Relative Strength Index (RSI)	38.64
Average Volume (20 Days)	2,552,751

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shandong Buchang Pharmaceuticals had revenue of CNY 11.72 billion and -195.75 million in losses. Loss per share was -0.18.

Revenue	11.72B
Gross Profit	7.23B
Operating Income	591.61M
Pretax Income	-65.76M
Net Income	-195.75M
EBITDA	934.34M
EBIT	591.61M
Loss Per Share	-0.18

Full Income Statement

Balance Sheet

The company has 1.61 billion in cash and 3.99 billion in debt, giving a net cash position of -2.38 billion or -2.21 per share.

Cash & Cash Equivalents	1.61B
Total Debt	3.99B
Net Cash	-2.38B
Net Cash Per Share	-2.21
Equity (Book Value)	11.00B
Book Value Per Share	10.46
Working Capital	1.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 33.73 million and capital expenditures -414.79 million, giving a free cash flow of -381.06 million.

Operating Cash Flow	33.73M
Capital Expenditures	-414.79M
Free Cash Flow	-381.06M
FCF Per Share	-0.35

Full Cash Flow Statement

Margins

Gross margin is 61.69%, with operating and profit margins of 5.05% and -1.67%.

Gross Margin	61.69%
Operating Margin	5.05%
Pretax Margin	-0.56%
Profit Margin	-1.67%
EBITDA Margin	7.97%
EBIT Margin	5.05%
FCF Margin	-3.25%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.86%.

Dividend Per Share	0.13
Dividend Yield	0.86%
Dividend Growth (YoY)	-86.88%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.42%
Shareholder Yield	1.28%
Earnings Yield	-1.22%
FCF Yield	-2.42%

Dividend Details

Stock Splits

The last stock split was on August 19, 2019. It was a forward split with a ratio of 1.3.

Last Split Date	Aug 19, 2019
Split Type	Forward
Split Ratio	1.3